IBDEI01W ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2063,2)
 ;;=^267542
 ;;^UTILITY(U,$J,358.3,2064,0)
 ;;=205.92^^23^167^63
 ;;^UTILITY(U,$J,358.3,2064,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2064,1,1,0)
 ;;=1^205.92
 ;;^UTILITY(U,$J,358.3,2064,1,8,0)
 ;;=8^Unspec Myeloid Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,2064,2)
 ;;=^336475
 ;;^UTILITY(U,$J,358.3,2065,0)
 ;;=206.00^^23^167^6
 ;;^UTILITY(U,$J,358.3,2065,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2065,1,1,0)
 ;;=1^206.00
 ;;^UTILITY(U,$J,358.3,2065,1,8,0)
 ;;=8^Acute Monocytic Leuk w/o Remission
 ;;^UTILITY(U,$J,358.3,2065,2)
 ;;=^336861
 ;;^UTILITY(U,$J,358.3,2066,0)
 ;;=206.01^^23^167^5
 ;;^UTILITY(U,$J,358.3,2066,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2066,1,1,0)
 ;;=1^206.01
 ;;^UTILITY(U,$J,358.3,2066,1,8,0)
 ;;=8^Acute Monocytic Leuk in Remission
 ;;^UTILITY(U,$J,358.3,2066,2)
 ;;=^267544
 ;;^UTILITY(U,$J,358.3,2067,0)
 ;;=206.02^^23^167^4
 ;;^UTILITY(U,$J,358.3,2067,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2067,1,1,0)
 ;;=1^206.02
 ;;^UTILITY(U,$J,358.3,2067,1,8,0)
 ;;=8^Acute Monocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,2067,2)
 ;;=^336476
 ;;^UTILITY(U,$J,358.3,2068,0)
 ;;=206.10^^23^167^15
 ;;^UTILITY(U,$J,358.3,2068,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2068,1,1,0)
 ;;=1^206.10
 ;;^UTILITY(U,$J,358.3,2068,1,8,0)
 ;;=8^Chr Monocytic Leuk w/o Remission
 ;;^UTILITY(U,$J,358.3,2068,2)
 ;;=^336862
 ;;^UTILITY(U,$J,358.3,2069,0)
 ;;=206.11^^23^167^14
 ;;^UTILITY(U,$J,358.3,2069,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2069,1,1,0)
 ;;=1^206.11
 ;;^UTILITY(U,$J,358.3,2069,1,8,0)
 ;;=8^Chr Monocytic Leuk in Remission
 ;;^UTILITY(U,$J,358.3,2069,2)
 ;;=^267546
 ;;^UTILITY(U,$J,358.3,2070,0)
 ;;=206.12^^23^167^13
 ;;^UTILITY(U,$J,358.3,2070,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2070,1,1,0)
 ;;=1^206.12
 ;;^UTILITY(U,$J,358.3,2070,1,8,0)
 ;;=8^Chr Monocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,2070,2)
 ;;=^336477
 ;;^UTILITY(U,$J,358.3,2071,0)
 ;;=206.20^^23^167^55
 ;;^UTILITY(U,$J,358.3,2071,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2071,1,1,0)
 ;;=1^206.20
 ;;^UTILITY(U,$J,358.3,2071,1,8,0)
 ;;=8^Subacute Monocytic Leuk w/o Remiss
 ;;^UTILITY(U,$J,358.3,2071,2)
 ;;=^336863
 ;;^UTILITY(U,$J,358.3,2072,0)
 ;;=206.21^^23^167^54
 ;;^UTILITY(U,$J,358.3,2072,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2072,1,1,0)
 ;;=1^206.21
 ;;^UTILITY(U,$J,358.3,2072,1,8,0)
 ;;=8^Subacute Monocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,2072,2)
 ;;=^267548
 ;;^UTILITY(U,$J,358.3,2073,0)
 ;;=206.22^^23^167^56
 ;;^UTILITY(U,$J,358.3,2073,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2073,1,1,0)
 ;;=1^206.22
 ;;^UTILITY(U,$J,358.3,2073,1,8,0)
 ;;=8^Subacute Monocytic Leuk w/o Remiss
 ;;^UTILITY(U,$J,358.3,2073,2)
 ;;=^336478
 ;;^UTILITY(U,$J,358.3,2074,0)
 ;;=206.80^^23^167^41
 ;;^UTILITY(U,$J,358.3,2074,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2074,1,1,0)
 ;;=1^206.80
 ;;^UTILITY(U,$J,358.3,2074,1,8,0)
 ;;=8^Oth Monocytic Leuk w/ Remission
 ;;^UTILITY(U,$J,358.3,2074,2)
 ;;=^336864
 ;;^UTILITY(U,$J,358.3,2075,0)
 ;;=206.81^^23^167^40
 ;;^UTILITY(U,$J,358.3,2075,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2075,1,1,0)
 ;;=1^206.81
 ;;^UTILITY(U,$J,358.3,2075,1,8,0)
 ;;=8^Oth Monocytic Leuk w/ Remiss
 ;;^UTILITY(U,$J,358.3,2075,2)
 ;;=^267551
 ;;^UTILITY(U,$J,358.3,2076,0)
 ;;=206.82^^23^167^39
 ;;^UTILITY(U,$J,358.3,2076,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2076,1,1,0)
 ;;=1^206.82
 ;;^UTILITY(U,$J,358.3,2076,1,8,0)
 ;;=8^Oth Monocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,2076,2)
 ;;=^336479
 ;;^UTILITY(U,$J,358.3,2077,0)
 ;;=206.90^^23^167^62
 ;;^UTILITY(U,$J,358.3,2077,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2077,1,1,0)
 ;;=1^206.90
 ;;^UTILITY(U,$J,358.3,2077,1,8,0)
 ;;=8^Unspec Monocytic Leuk w/o Remiss
 ;;^UTILITY(U,$J,358.3,2077,2)
 ;;=^336865
 ;;^UTILITY(U,$J,358.3,2078,0)
 ;;=206.91^^23^167^61
 ;;^UTILITY(U,$J,358.3,2078,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2078,1,1,0)
 ;;=1^206.91
 ;;^UTILITY(U,$J,358.3,2078,1,8,0)
 ;;=8^Unspec Monocytic Leuk in Remiss
 ;;^UTILITY(U,$J,358.3,2078,2)
 ;;=^267554
 ;;^UTILITY(U,$J,358.3,2079,0)
 ;;=206.92^^23^167^60
 ;;^UTILITY(U,$J,358.3,2079,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2079,1,1,0)
 ;;=1^206.92
 ;;^UTILITY(U,$J,358.3,2079,1,8,0)
 ;;=8^Unspec Monocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,2079,2)
 ;;=^336480
 ;;^UTILITY(U,$J,358.3,2080,0)
 ;;=207.00^^23^167^3
 ;;^UTILITY(U,$J,358.3,2080,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2080,1,1,0)
 ;;=1^207.00
 ;;^UTILITY(U,$J,358.3,2080,1,8,0)
 ;;=8^AC Eryth & Erythroleuk w/o Remiss
 ;;^UTILITY(U,$J,358.3,2080,2)
 ;;=^336866
 ;;^UTILITY(U,$J,358.3,2081,0)
 ;;=207.01^^23^167^1
 ;;^UTILITY(U,$J,358.3,2081,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2081,1,1,0)
 ;;=1^207.01
 ;;^UTILITY(U,$J,358.3,2081,1,8,0)
 ;;=8^AC Eryth & Erythroleuk in Relapse
 ;;^UTILITY(U,$J,358.3,2081,2)
 ;;=^267556
 ;;^UTILITY(U,$J,358.3,2082,0)
 ;;=207.02^^23^167^2
 ;;^UTILITY(U,$J,358.3,2082,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2082,1,1,0)
 ;;=1^207.02
 ;;^UTILITY(U,$J,358.3,2082,1,8,0)
 ;;=8^AC Eryth & Erythroleuk in Relapse
 ;;^UTILITY(U,$J,358.3,2082,2)
 ;;=^336481
 ;;^UTILITY(U,$J,358.3,2083,0)
 ;;=207.10^^23^167^9
 ;;^UTILITY(U,$J,358.3,2083,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2083,1,1,0)
 ;;=1^207.10
 ;;^UTILITY(U,$J,358.3,2083,1,8,0)
 ;;=8^Chr Erythremia w/o Remission
 ;;^UTILITY(U,$J,358.3,2083,2)
 ;;=^336867
 ;;^UTILITY(U,$J,358.3,2084,0)
 ;;=207.11^^23^167^8
 ;;^UTILITY(U,$J,358.3,2084,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2084,1,1,0)
 ;;=1^207.11
 ;;^UTILITY(U,$J,358.3,2084,1,8,0)
 ;;=8^Chr Erythremia in Remission
 ;;^UTILITY(U,$J,358.3,2084,2)
 ;;=^267558
 ;;^UTILITY(U,$J,358.3,2085,0)
 ;;=207.12^^23^167^7
 ;;^UTILITY(U,$J,358.3,2085,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2085,1,1,0)
 ;;=1^207.12
 ;;^UTILITY(U,$J,358.3,2085,1,8,0)
 ;;=8^Chr Erythremia in Relapse
 ;;^UTILITY(U,$J,358.3,2085,2)
 ;;=^336482
 ;;^UTILITY(U,$J,358.3,2086,0)
 ;;=207.20^^23^167^28
 ;;^UTILITY(U,$J,358.3,2086,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2086,1,1,0)
 ;;=1^207.20
 ;;^UTILITY(U,$J,358.3,2086,1,8,0)
 ;;=8^Megakaryocytic Leuk w/o Remission
 ;;^UTILITY(U,$J,358.3,2086,2)
 ;;=^336868
 ;;^UTILITY(U,$J,358.3,2087,0)
 ;;=207.21^^23^167^27
 ;;^UTILITY(U,$J,358.3,2087,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2087,1,1,0)
 ;;=1^207.21
 ;;^UTILITY(U,$J,358.3,2087,1,8,0)
 ;;=8^Megakaryocytic Leuk in Remission
 ;;^UTILITY(U,$J,358.3,2087,2)
 ;;=^267560
 ;;^UTILITY(U,$J,358.3,2088,0)
 ;;=207.22^^23^167^26
 ;;^UTILITY(U,$J,358.3,2088,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2088,1,1,0)
 ;;=1^207.22
 ;;^UTILITY(U,$J,358.3,2088,1,8,0)
 ;;=8^Megakaryocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,2088,2)
 ;;=^336483
 ;;^UTILITY(U,$J,358.3,2089,0)
 ;;=207.80^^23^167^47
 ;;^UTILITY(U,$J,358.3,2089,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2089,1,1,0)
 ;;=1^207.80
 ;;^UTILITY(U,$J,358.3,2089,1,8,0)
 ;;=8^Oth Spec Leukemia w/o Remission
 ;;^UTILITY(U,$J,358.3,2089,2)
 ;;=^336869
 ;;^UTILITY(U,$J,358.3,2090,0)
 ;;=207.81^^23^167^46
 ;;^UTILITY(U,$J,358.3,2090,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2090,1,1,0)
 ;;=1^207.81
 ;;^UTILITY(U,$J,358.3,2090,1,8,0)
 ;;=8^Oth Spec Leukemia in Remission
 ;;^UTILITY(U,$J,358.3,2090,2)
 ;;=^267562
 ;;^UTILITY(U,$J,358.3,2091,0)
 ;;=207.82^^23^167^45
 ;;^UTILITY(U,$J,358.3,2091,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2091,1,1,0)
 ;;=1^207.82
 ;;^UTILITY(U,$J,358.3,2091,1,8,0)
 ;;=8^Oth Spec Leukemia in Relapse
 ;;^UTILITY(U,$J,358.3,2091,2)
 ;;=^336484
 ;;^UTILITY(U,$J,358.3,2092,0)
 ;;=208.00^^23^167^21
 ;;^UTILITY(U,$J,358.3,2092,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2092,1,1,0)
 ;;=1^208.00
 ;;^UTILITY(U,$J,358.3,2092,1,8,0)
 ;;=8^Leukemia Unspec w/o Remission
 ;;^UTILITY(U,$J,358.3,2092,2)
 ;;=^336870
 ;;^UTILITY(U,$J,358.3,2093,0)
 ;;=208.01^^23^167^20
 ;;^UTILITY(U,$J,358.3,2093,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2093,1,1,0)
 ;;=1^208.01
 ;;^UTILITY(U,$J,358.3,2093,1,8,0)
 ;;=8^Leukemia Unspec in Remission
 ;;^UTILITY(U,$J,358.3,2093,2)
 ;;=^267566
 ;;^UTILITY(U,$J,358.3,2094,0)
 ;;=208.02^^23^167^19
 ;;^UTILITY(U,$J,358.3,2094,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2094,1,1,0)
 ;;=1^208.02
 ;;^UTILITY(U,$J,358.3,2094,1,8,0)
 ;;=8^Leukemia Unspec in Relapse
 ;;^UTILITY(U,$J,358.3,2094,2)
 ;;=^336485
 ;;^UTILITY(U,$J,358.3,2095,0)
 ;;=208.10^^23^167^12
 ;;^UTILITY(U,$J,358.3,2095,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2095,1,1,0)
 ;;=1^208.10
 ;;^UTILITY(U,$J,358.3,2095,1,8,0)
 ;;=8^Chr Leukemia w/o Remission
 ;;^UTILITY(U,$J,358.3,2095,2)
 ;;=^336871
 ;;^UTILITY(U,$J,358.3,2096,0)
 ;;=208.11^^23^167^11
 ;;^UTILITY(U,$J,358.3,2096,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2096,1,1,0)
 ;;=1^208.11
 ;;^UTILITY(U,$J,358.3,2096,1,8,0)
 ;;=8^Chr Leukemia in Remission
 ;;^UTILITY(U,$J,358.3,2096,2)
 ;;=^267569
 ;;^UTILITY(U,$J,358.3,2097,0)
 ;;=208.12^^23^167^10
 ;;^UTILITY(U,$J,358.3,2097,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2097,1,1,0)
 ;;=1^208.12
 ;;^UTILITY(U,$J,358.3,2097,1,8,0)
 ;;=8^Chr Leukemia in Relapse
 ;;^UTILITY(U,$J,358.3,2097,2)
 ;;=^336486
 ;;^UTILITY(U,$J,358.3,2098,0)
 ;;=208.20^^23^167^53
 ;;^UTILITY(U,$J,358.3,2098,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2098,1,1,0)
 ;;=1^208.20
 ;;^UTILITY(U,$J,358.3,2098,1,8,0)
 ;;=8^Subacute Leukemia w/o Remission
 ;;^UTILITY(U,$J,358.3,2098,2)
 ;;=^336872
 ;;^UTILITY(U,$J,358.3,2099,0)
 ;;=208.21^^23^167^52
 ;;^UTILITY(U,$J,358.3,2099,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2099,1,1,0)
 ;;=1^208.21
 ;;^UTILITY(U,$J,358.3,2099,1,8,0)
 ;;=8^Subacute Leukemia in Remission
 ;;^UTILITY(U,$J,358.3,2099,2)
 ;;=^267572
 ;;^UTILITY(U,$J,358.3,2100,0)
 ;;=208.22^^23^167^51
 ;;^UTILITY(U,$J,358.3,2100,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2100,1,1,0)
 ;;=1^208.22
